First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children an open-label, randomised phase 2/3 trial
A. Babiker H Castro nee Green; A Compagnucci; S Fiscus; C Giaquinto; D Gibbs; L Harper; L Harrison; H. D Hughes; R McKinney; A Melvin; L Mofenson; Y Saidi; M. E Smith; G Tudor-Williams; A. S Walker; Marisa Márcia Mussi-Pinhata
The Lancet Infectious Diseases London v. 11, n. 4, p. 273-283, 2011
London 2011
Localização:
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 2261642 estantes deslizantes )(Acessar)
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children an open-label, randomised phase 2/3 trial
A. Babiker H Castro nee Green; A Compagnucci; S Fiscus; C Giaquinto; D Gibbs; L Harper; L Harrison; H. D Hughes; R McKinney; A Melvin; L Mofenson; Y Saidi; M. E Smith; G Tudor-Williams; A. S Walker; Marisa Márcia Mussi-Pinhata
The Lancet Infectious Diseases London v. 11, n. 4, p. 273-283, 2011
London 2011
Localização:
FMRP - Fac. Medicina de Ribeirão Preto
(pcd 2261642 estantes deslizantes )(Acessar)